In BC, IRS-1 and its phosphorylated form (p-IRS1) are key mediators in the insulin and insulin-like growth factor (IGF) signalling pathways and play crucial roles in the cellular signalling pathways influencing tumour progression and treatment response [24]. This evidence concerns the gene IGF1 and breast cancer.